First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study
Crossref DOI link: https://doi.org/10.1007/s10147-015-0796-5
Published Online: 2015-02-25
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Ying
Yue, Han
Xu, Shuning
Wang, Feng
Ma, Ning
Li, Ke
Qiao, Lei
Wang, Jufeng
Text and Data Mining valid from 2015-02-25